# EDGAR Filing Document

**Accession Number:** 0002083070
**File Stem:** 0002083070-25-000002
**Filing Date:** 2025-8
**Character Count:** 7696
**Document Hash:** d2b0b0ebb6f1ca20f6356d2f74e7d41a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002083070-25-000002.hdr.sgml**: 20250827

**ACCESSION NUMBER**: 0002083070-25-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250827

**FILED AS OF DATE**: 20250827

**DATE AS OF CHANGE**: 20250827

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wherley Joel L
- **CENTRAL INDEX KEY:** 0002083070

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08351
- **FILM NUMBER:** 251263074

**MAIL ADDRESS:**
- **STREET 1:** 255 EAST FIFTH STREET
- **STREET 2:** SUITE 1050
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45202
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CHEMED CORP
- **CENTRAL INDEX KEY:** 0000019584
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HOME HEALTH CARE SERVICES [8082]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 310791746
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** SUITE 2600
- **STREET 2:** 255 E FIFTH ST
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45202
- **BUSINESS PHONE:** (513)762-6690

**MAIL ADDRESS:**
- **STREET 1:** SUITE 2600
- **STREET 2:** 255 E FIFTH STREET
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45202-4726

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ROTO-ROOTER INC
- **DATE OF NAME CHANGE:** 20030613

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMED CORP
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wherley Joel L<br><sub>(Last) (First) (Middle)</sub><br>255 EAST FIFTH STREET<br>SUITE 2600<br><sub>(Street)</sub><br>CINCINNATI, OH 45202<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>CHEMED CORP [ CHE ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-08-27 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_CEO - Vitas Healthcare_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Capital Stock | 659 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy with tandem tax withholding) | <sup>(1)</sup> | 2028-10-25 | Capital Stock | 6961 | $509.46 | D |  |
| Stock Option (right to buy with tandem tax withholding) | <sup>(2)</sup> | 2029-10-22 | Capital Stock | 8382 | $597.70 | D |  |
| Performance Stock Unit | <sup>(3)</sup> | <sup>(3)</sup> | Capital Stock | 220 | <sup>(4)</sup> | D |  |
| Performance Stock Unit | <sup>(5)</sup> | <sup>(5)</sup> | Capital Stock | 220 | <sup>(4)</sup> | D |  |
| Performance Stock Unit | <sup>(6)</sup> | <sup>(6)</sup> | Capital Stock | 223 | <sup>(4)</sup> | D |  |
| Performance Stock Unit | <sup>(7)</sup> | <sup>(7)</sup> | Capital Stock | 223 | <sup>(4)</sup> | D |  |
| Performance Stock Unit | <sup>(8)</sup> | <sup>(8)</sup> | Capital Stock | 312 | <sup>(4)</sup> | D |  |
| Performance Stock Unit | <sup>(9)</sup> | <sup>(9)</sup> | Capital Stock | 312 | <sup>(4)</sup> | D |  |

---

### Footnotes:

(1) Vesting in three equal annual installments commencing 10/25/2024.

(2) Vesting in three equal annual installments commencing 10/22/2025.

(3) The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2023 through December 31, 2025 with the determination of such performance level to be made no later than March 15, 2026 and earned shares of Capital Stock to be delivered thereafter.

(4) Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock.

(5) The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2023 through December 31, 2025 with the determination of such performance level to be made no later than March 15, 2026 and earned shares of Capital Stock to be delivered thereafter.

(6) The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2024 through December 31, 2026 with the determination of such performance level to be made no later than March 15, 2027 and earned shares of Capital Stock to be delivered thereafter.

(7) The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2024 through December 31, 2026 with the determination of such performance level to be made no later than March 15, 2027 and earned shares of Capital Stock to be delivered thereafter.

(8) The restricted stock units vest based on the extent to which the Company achieves certain Earnings per Share performance targets over a performance period of January 1, 2025 through December 31, 2027 with the determination of such performance level to be made no later than March 15, 2028 and earned shares of Capital Stock to be delivered thereafter.

(9) The restricted stock units vest based on the extent to which the Company achieves certain Total Shareholder Return performance targets over a performance period of January 1, 2025 through December 31, 2027 with the determination of such performance level to be made no later than March 15, 2028 and earned shares of Capital Stock to be delivered thereafter.

**Signature:** Joel L Wherley  
**Date:** 2025-08-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**